The anti-diabetic drug miglitol is protective against anginal ischaemia through a mechanism independent of regional myocardial blood flow in the dog

Clinical and Experimental Pharmacology and Physiology

Volumn 32, Issue 10, 2005, Pages 805-810

  Uno, Yoshihiro ^a   Minatoguchi, Shinya ^a   Arai, Masazumi ^a   Wang, Ningyuan ^a   Chen, Xue Hai ^a   Hashimoto, Kazuaki ^a   Lu, Cuanjiang ^a   Takemura, Genzou ^a   Fujiwara, Hisayoshi ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

1,6 glucosidase inhibitor; Ischaemia; Lactate; Miglitol; Regional myocardial blood flow

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; ANTIDIABETIC AGENT; LACTIC ACID; MICROSPHERE; MIGLITOL; PHENYLEPHRINE; DRUG DERIVATIVE; GLUCOSAMINE; IMINOSUGAR; LACTIC ACID DERIVATIVE;

ANGINA PECTORIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DOG; DRUG MECHANISM; ELECTRODE; EPICARDIUM; GLYCOGENOLYSIS; HEART ATRIUM PACING; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEART PROTECTION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MICRODIALYSIS; NONHUMAN; ST SEGMENT; ST SEGMENT DEPRESSION; STATISTICAL SIGNIFICANCE; ANIMAL; BLOOD; BLOOD PRESSURE; COMPARATIVE STUDY; CORONARY ARTERY BLOOD FLOW; DRUG EFFECT; GLUCOSE BLOOD LEVEL; HEART MUSCLE; HEART RATE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ANGINA PECTORIS; ANIMALS; BLOOD GLUCOSE; BLOOD PRESSURE; CORONARY CIRCULATION; DOGS; GLUCOSAMINE; HEART RATE; HYPOGLYCEMIC AGENTS; IMINO PYRANOSES; LACTATES; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIUM;

EID: 33644689398     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2005.04269.x     Document Type: Article

References (22)

1. Murry CE Jennings RB Reimer KA. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 1986 74 : 1124 36.
2. Murry CE Richard VJ Reimer KA Jennings RB. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ. Res. 1990 66 : 913 31.
3. Asimakis GK Inners-McBride K Medellin G Conti VR. Ischemic preconditioning attenuates acidosis and postischemic dysfunction in isolated rat heart. Am. J. Physiol. 1992 263 : H887 94.
4. Kida M Fujiwara H Ishida M et al. Ischemic preconditioning preserves creatine phosphate and intracellular pH. Circulation 1993 84 : 2495 503.
5. Wolfe CL Sievers RE Visseren FL Donnelly TJ. Loss of myocardial protection after preconditioning correlates with the time course of glycogen recovery within the preconditioned segment. Circulation 1993 87 : 881 92.
6. Schaefer S Carr LJ Prussel E Ramasamy R. Effect of glycogen depletion on ischemic injury in isolated rat hearts: Insights into preconditioning. Am. J. Physiol. 1995 268 : H935 44.
7. King LM Opie LH. Does preconditioning act by glycogen depletion in the isolated rat heart? J. Mol. Cell. Cardiol. 1996 28 : 2305 21.
8. Bischoff H. Pharmacology of α-glucosidase inhibition. Eur. J. Clin. Invest. 1994 24 ( Suppl. 3 3 10.
9. Minatoguchi S Arai M Uno Y et al. A novel anti-diabetic drug, miglitol, markedly reduces myocardial infarct size in rabbits. Br. J. Pharmacol. 1999 128 : 1667 72.
10. Hale SL Alker KJ Kloner RA. Evaluation of non-radioactive, colored microspheres for measurement of regional myocardial blood flow in dogs. Circulation 1988 78 : 428 34.
11. Bergmyer HU. Methods of Enzymatic Analysis, Vol. 4. Academic Press, New York. 1974.
12. Hauser TH Dorbala S Sulaiman A Di Carli MF. Quantitative relation of ST-segment depression during exercise to the magnitude of myocardial ischemia as assessed by single-photon emission computed tomographic myocardial perfusion imaging. Am. J. Cardiol. 2004 94 : 703 8.
13. Watanabe T Harumi K Akutsu Y et al. Correlation between exercise-induced ischemic ST-segment depression and myocardial blood flow quantified by positron emission tomography. Am. Heart J. 1998 136 : 533 42.
14. Utsunomiya T Satoh S Ikegaki I et al. Antianginal effects of hydroxyfasudil, a Rho-kinase inhibitor, in a canine model of effort angina. Br. J. Pharmacol. 2001 134 : 1724 30.
15. Sugiyama A Hashimoto K. Antiischemic effects of CP-060S, an inhibitor of pathologically modified sodium channels, assessed in the canine experimental model of angina pectoris. J. Cardiovasc. Pharmacol. 1999 33 : 70 7.
16. Becker RC Alpert JS. Electrocardiographic ST segment depression in coronary heart disease. Am. Heart J. 1988 115 : 862 8.
17. Matsubara T Minatoguchi S Matsuo H et al. Three minute, but not one minute, ischemia and nicorandil have a preconditioning effect in patients with coronary artery disease. J. Am. Coll. Cardiol. 2000 35 : 345 51.
18. Schwartz LM Sebbag L Jennings RB et al. Duration and reinstatement of myocardial protection against infarction by ischemic preconditioning in open chest dogs. J. Mol. Cell. Cardiol. 2001 33 : 1561 70.
19. Opie LH. Should calcium antagonist be used after myocardial infarction? Ischemia selectivity versus vascular selectivity. Cardiovasc. Drugs Ther. 1993 6 : 19 24.
20. Bassenge E Stewart DJ. Interdependence of pharmacologically-induced and endothelium-mediated coronary vasodilation in antianginal therapy. Cardiovasc. Drugs Ther. 1988 2 : 27 34.
21. Kowallik P Schulz R Guth BD et al. Measurement of regional myocardial blood flow with multiple colored microspheres. Circulation 1991 83 : 974 82.
22. Scott LJ Spencer CM. Miglitol, a review of its therapeutic potential in type 2 diabetes mellitus. Drugs 2000 59 : 521 49.